<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><description>【国内外药讯，医药市场，医药数据分享】</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 12 Jun 2021 10:00:55 +0800</pubDate><image><url>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</url><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>创历史：某上市医药企业，出资98亿砸进基金</title><link>https://mp.weixin.qq.com/s/x1IYmdWZ571uz6N_4jY3Bg</link><description></description><content:encoded><![CDATA[创历史：某上市医药企业，出资98亿砸进基金]]></content:encoded><pubDate>Sat, 12 Jun 2021 07:47:24 +0800</pubDate></item><item><title>乳腺癌大癌种：恒瑞CDK4/6即将上市，通用名已出！</title><link>https://mp.weixin.qq.com/s/T_4m_If8OP_RyZ8dHRbegg</link><description></description><content:encoded><![CDATA[乳腺癌大癌种：恒瑞CDK4/6即将上市，通用名已出！]]></content:encoded><pubDate>Wed, 09 Jun 2021 14:51:06 +0800</pubDate></item><item><title>估值惊人，头部基金疯抢：这家国内mRNA药企融资12亿</title><link>https://mp.weixin.qq.com/s/ZznXRACR0VD8YJ1Lz0BkuQ</link><description></description><content:encoded><![CDATA[估值惊人，头部基金疯抢：这家国内mRNA药企融资12亿]]></content:encoded><pubDate>Thu, 03 Jun 2021 06:45:39 +0800</pubDate></item><item><title>创响生物完成1亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/cptwrTyeSNtZrp6PD9syTA</link><description></description><content:encoded><![CDATA[创响生物完成1亿美元C轮融资]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:38:05 +0800</pubDate></item><item><title>启辰生生物完成数亿元Pre A+轮融资，专注mRNA新药开发</title><link>https://mp.weixin.qq.com/s/dymkNPp7KSApVsHgCUaJzQ</link><description></description><content:encoded><![CDATA[启辰生生物完成数亿元Pre A+轮融资，专注mRNA新药开发]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:38:05 +0800</pubDate></item><item><title>投入超6200万元，复星医药的CD73抗体获FDA批临床</title><link>https://mp.weixin.qq.com/s/_EQrjx-CMXn3WmVcnqIiZw</link><description></description><content:encoded><![CDATA[投入超6200万元，复星医药的CD73抗体获FDA批临床]]></content:encoded><pubDate>Mon, 31 May 2021 20:40:34 +0800</pubDate></item><item><title>投入超8200万元，复星MEK1/2抑制剂获FDA批准临床</title><link>https://mp.weixin.qq.com/s/Yfj8X11-1F80FmkrsTMK8A</link><description></description><content:encoded><![CDATA[投入超8200万元，复星MEK1/2抑制剂获FDA批准临床]]></content:encoded><pubDate>Mon, 31 May 2021 20:40:34 +0800</pubDate></item><item><title>沃森、清华等联合开发的重组新冠疫苗获批临床</title><link>https://mp.weixin.qq.com/s/PUuAMwhXA6zXWDzyiTdtyg</link><description></description><content:encoded><![CDATA[沃森、清华等联合开发的重组新冠疫苗获批临床]]></content:encoded><pubDate>Sun, 30 May 2021 06:22:03 +0800</pubDate></item><item><title>亿一生物F-627上市申请获得FDA正式受理，有望明年获批上市</title><link>https://mp.weixin.qq.com/s/cERXIwoGFTujlW4lXWygfg</link><description></description><content:encoded><![CDATA[亿一生物F-627上市申请获得FDA正式受理，有望明年获批上市]]></content:encoded><pubDate>Sun, 30 May 2021 06:22:03 +0800</pubDate></item><item><title>博锐生物3款1类创新型生物制品临床试验申请先后获受理</title><link>https://mp.weixin.qq.com/s/SeXP1WDadp7j4obmFaqbYw</link><description></description><content:encoded><![CDATA[博锐生物3款1类创新型生物制品临床试验申请先后获受理]]></content:encoded><pubDate>Fri, 28 May 2021 16:09:01 +0800</pubDate></item><item><title>加科思KRAS G12C抑制剂IND中国获批 将启动中美多中心临床</title><link>https://mp.weixin.qq.com/s/HJzsY4KT9L8uiePPmsDXhw</link><description></description><content:encoded><![CDATA[加科思KRAS G12C抑制剂IND中国获批 将启动中美多中心临床]]></content:encoded><pubDate>Fri, 28 May 2021 16:09:01 +0800</pubDate></item><item><title>估值近40亿元！亚虹提交科创板IPO申请，拟募资20.7亿元</title><link>https://mp.weixin.qq.com/s/gc_VPC6PYpgFQE6W2YycqA</link><description></description><content:encoded><![CDATA[估值近40亿元！亚虹提交科创板IPO申请，拟募资20.7亿元]]></content:encoded><pubDate>Thu, 27 May 2021 12:34:42 +0800</pubDate></item><item><title>传奇生物BCMA CAR-T有望年底获FDA批准上市</title><link>https://mp.weixin.qq.com/s/7OAAlL5jNyQ3ILF66bxehw</link><description></description><content:encoded><![CDATA[传奇生物BCMA CAR-T有望年底获FDA批准上市]]></content:encoded><pubDate>Thu, 27 May 2021 12:34:42 +0800</pubDate></item><item><title>新冠疫苗如此赚钱？这家企业3个月净利润近100亿元</title><link>https://mp.weixin.qq.com/s/RS1hj6GDaBMplEvmVO1RxQ</link><description></description><content:encoded><![CDATA[新冠疫苗如此赚钱？这家企业3个月净利润近100亿元]]></content:encoded><pubDate>Tue, 25 May 2021 16:15:30 +0800</pubDate></item></channel></rss>